Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
MedTech
FTC aims to stop Edwards’ acquisition of JenaValve
The FTC moved to block Edwards Lifesciences’ buyout of JenaValve and its heart implant for aortic regurgitation, slated for FDA approval this year.
Conor Hale
Aug 7, 2025 11:33am
Alcon sees Staar Surgical for $1.5B deal
Aug 5, 2025 11:00am
Xoma shops for struggling biotechs, buying HilleVax and Lava
Aug 4, 2025 9:27am
AbbVie in talks over $1B Gilgamesh buyout: report
Jul 31, 2025 7:48am
Bausch Health bags phase 3-ready liver prospect in $63M buyout
Jul 29, 2025 9:35am
Sanofi inks $1.15B buyout to boost RSV pipeline
Jul 22, 2025 4:20am
